USPTO Granted Patents = 41 (Patent Applications = 5)
CIPO Patents = 7 (Patent Applications = 2)
EPO Patents = 18 (Patent Applications = 14)
Average Co-Inventor Count = 8.7
ph-index = 13
Forward Citations = 413(Granted Patents)
Location History:
- Cambridge, GA (2014)
- Cambridge, GB (2011 - 2019)
- Zagreb, HR (2016 - 2023)
Company Filing History:
Astex Therapeutics Limited
The Institute of Cancer Research: Royal Cancer Hospital
Cancer Research Technology Limited
4. 1 out of 1
Fidelta D.o.o.
5. 1 out of 1
Selvita D.o.o.
6. 1 out of 116
Galapagos Nv
where one patent can have more than one assignee
Years Active: 2011-2023
Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bicyclic Heterocycle Compounds
Seco Macrolide Compounds
Pyrrolopyrimidine Derivatives
Pyrazolyl Quinoxaline Kinase Inhibitors
Pteridines as FGFR Inhibitors
Substituted Quinoxalines
Quinolines as FGFR Modulators
Protein Kinase Modulators
Imidazopyridine Derivatives
FGFR Pharmacophore Compounds
Ortho-condensed Pyridine Derivatives
Cancer Therapeutics
41 patents (USPTO):Explore Patents
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I regret to inform you that I can only provide information related to these specific topics.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
5 patents pending:
Please report any incorrect information to support@idiyas.com
7 patents (CIPO):
Please report any incorrect information to support@idiyas.com
2 patents pending (CIPO):
Please report any incorrect information to support@idiyas.com
18 patents (EPO):
Please report any incorrect information to support@idiyas.com
14 patents pending (EPO):
Please report any incorrect information to support@idiyas.com